Keith Barclay
Chief Investment Officer bij Elasmogen Ltd.
Profiel
Keith Barclay currently works at Elasmogen Ltd., as Director & Investor Director and Business Growth Fund Ltd, as Principal from 2015.
Mr. Barclay received his graduate degree from the University of Aberdeen.
Actieve functies van Keith Barclay
| Bedrijven | Functie | Begin |
|---|---|---|
Business Growth Fund Ltd
 Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the UK. | Private Equity Investor | 01-11-2015 |
Elasmogen Ltd.
 Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Chief Investment Officer | - |
Opleiding van Keith Barclay
| University of Aberdeen | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the UK. | Finance |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Health Technology |
